Professional Documents
Culture Documents
TB and Hiv/Aids: Care & Treatment Unit
TB and Hiv/Aids: Care & Treatment Unit
40
Smear neg/Culture pos 5 (3.3%)
30
20
10
Smear neg/Culture neg: 43 (29%)
0
Smear pos/Culture neg:37 (25%)
Test statistics(2015): GeneXpert
Total GeneXpert 1252
MTB Not detected (N) 1073
MTB detected /Rif neg(T) 70
MTB detected / Rif detected ( RR) 4
MTB detected/ Rif Indeterminate (I) 7
Error 23
Invalid 63
No result 5
Results feedback and reports
• Results of AFB Smears and GeneXpert released
to requesting clinician within 24 hours.
• Critical results have been identified and are
immediately communicated to clinician.
• If RR in addition to clinician RTLC is informed
• Customer satisfaction survey of January 2016
does not show negative statements or
complaints for AFB smears or GeneXpert
TREATMENT
For new TB/HIV Patients, start ART within two
weeks of antTBRX
All TB Patient should start ART regardless of
CD4 count
Initiate co-trimoxazole prophylaxis to all PTB
patients regardless of CD4 count
Drug-drug interaction:Nevirapine and
atazanavir
• Regimes
New adult 2RHZE/4RH
All retreatment and defaulters
2RHZE/1RHZE/5RHZE
Rifampicin resistant
MDRTB RX
• DOT
-Treatment supporter
-DOT Nurse or HCW
Trends of TB at BMC, 2014-2016
TB AMONG NON-HIV
BMC Trends of TB/HIV co-Infection
Trends of Types of TB/HIV co-infection
2015
Annual Trends for types TB in HIV
2015/2016
WAY FOWARD
THE FUTURE OF BMC ON TB Dx & Rx
• Capacity building for TB culture
o Microscopy -AFB
o Gene expert/RIF
o ?Line probe assay (once negative
pressure is
o ?DST established)
o ?LAM test
o ?ADA test